Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines / MAZZOCCA A; GIUSTI S; HAMILTON AD; SEBTI SM; PANTALEO P; V. CARLONI. - In: MOLECULAR PHARMACOLOGY. - ISSN 0026-895X. - ELETTRONICO. - 63:(2003), pp. 159-166.
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines.
CARLONI, VINICIO
2003
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.